HARMONY BIOSCIENCES ANNOUNCES FILE ACCEPTANCE OF ITS NEW DRUG APPLICATION FOR PITOLISANT
Know more
News
Bioprojet will be taking part as sponsor for the 16th European Narcolepsy master class 17th May 2019 and for EUNN congress May 18 & 19
Know more
DATA ON ABUSE POTENTIAL OF PITOLISANT PRESENTED AT 2018 ESRS CONGRESS
Know more
HARMONY BIOSCIENCES PRESENTS 5-YEAR DATA ON PITOLISANT AT INTERNATIONAL NARCOLEPSY SYMPOSIUM
Know more
Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada
Know more
Bioprojet: Pitolisant Progresses Towards the U.S. Market
Know more
AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma in Austria, Nordic countries and Central Eastern Europe
Know more
Harmony biosciences acquires us rights to pitolisant from bioprojet; raises $270 million in equity financing
Know more